Company Filing History:
Years Active: 2011
Title: Innovations of Rang-Woon Park in Endothelial Cell Research
Introduction
Rang-Woon Park is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of biomedical research, particularly in the area of endothelial cell interactions. His work focuses on the development of peptides that can influence cellular behaviors, which has implications for various medical conditions.
Latest Patents
Rang-Woon Park holds a patent for the "Use of a peptide that interacts with αvβ3 integrin of endothelial cells." This invention relates to a method for inhibiting endothelial cell adhesion, migration, and angiogenesis. The peptide consists of at least 18 amino acids, including tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. The invention also provides a method for treating or preventing diseases related to angiogenesis using this peptide. He has 1 patent to his name.
Career Highlights
Rang-Woon Park is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His role at this institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His innovative work has the potential to lead to new therapeutic strategies for diseases associated with abnormal angiogenesis.
Collaborations
Rang-Woon Park has worked alongside notable colleagues such as Ju-Ock Nam and Jung-Eun Kim. Their collaborative efforts contribute to advancing research in endothelial cell biology and related applications.
Conclusion
Rang-Woon Park's contributions to the field of endothelial cell research through his innovative peptide technology highlight the importance of scientific collaboration and innovation. His work not only enhances our understanding of cellular interactions but also paves the way for potential medical advancements.